Get notified when TVTX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTravere names CMO Jula Inrig as Head of R&D following CRO retirement announcement
Filed June 16, 2026 · Period ending June 12, 2026 · ~1 min read
Key Changes
-
medium
Chief Medical Officer Jula Inrig promoted to Executive Vice President, Head of Research & Development effective July 1, 2026, consolidating R&D leadership under one executive.
Item 5.02 verify on EDGAR → -
medium
Chief Research Officer William Rote announced retirement effective February 17, 2027, marking his 10-year anniversary with Travere. He will continue in current role through retirement date.
Item 5.02 verify on EDGAR → -
low
Company plans consulting arrangement with retiring CRO Rote to maintain access to his expertise following February 2027 departure.
Item 5.02 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.
Partner
Trade TVTX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 16, 2026 5:06 PM